While the efficacy of IL-17A antagonists in inflammatory disorders has been well described, those on the cancer- and chemotherapy-associated cardiovascular diseases remain less explored. In this study, the potential protective effect of IL-17A neutralization was assessed in rat model of DOX-induced cardiotoxicity (DIC). This evidence concerns the gene IL17A and cancer.